123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors
The study is designed to study the safety and effectiveness of 123I-MIBG as a diagnostic imaging agent in evaluating patients with known or suspected neuroendocrine tumors.
Pheochromocytoma|Neuroblastoma|Paraganglioma|Medullary Thyroid Carcinoma|Carcinoid Tumors
DRUG: 123I-meta-iodobenzylguanidine
The study is designed to study the safety and effectiveness of 123I-MIBG as a diagnostic imaging agent in evaluating patients with known or suspected neuroendocrine tumors.